Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Biosimilar Therapeutic Antibodies industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Affitech
Binex
Affibody
3SBio (Shenyang Sunshine Pharmaceutical Co)
AbbVie
Daiichi Sankyo
BioCND
Daewoong Pharmaceutical Co
Affilogic
CytomX Therapeutics
BiOasis Technologies
Affimed Therapeutics
Biocad
Baliopharm
Ablynx
Allergan
Bio Farma
Bayer
By Type:
Type 1
Type 2
Type 3
By Application:
Application 1
Application 2
Application 3
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Biosimilar Therapeutic Antibodies Market Overview 2018-2029
-
1.1 China Biosimilar Therapeutic Antibodies Industry Development Overview
-
1.2 China Biosimilar Therapeutic Antibodies Industry Development History
-
1.3 China Biosimilar Therapeutic Antibodies Industry Market Size (2018-2029)
-
1.4 China Biosimilar Therapeutic Antibodies Market Analysis by Type from Production Side
-
1.4.1 China Biosimilar Therapeutic Antibodies Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)
-
1.4.2 China Biosimilar Therapeutic Antibodies Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)
-
1.4.3 China Biosimilar Therapeutic Antibodies Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)
-
1.5 China Biosimilar Therapeutic Antibodies Market Analysis by Application from Consumption End
-
1.5.1 China Biosimilar Therapeutic Antibodies Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)
-
1.5.2 China Biosimilar Therapeutic Antibodies Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)
-
1.5.3 China Biosimilar Therapeutic Antibodies Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)
-
1.6 China Biosimilar Therapeutic Antibodies Market Analysis by Region
-
1.6.1 North China Biosimilar Therapeutic Antibodies Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Biosimilar Therapeutic Antibodies Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Biosimilar Therapeutic Antibodies Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Biosimilar Therapeutic Antibodies Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Biosimilar Therapeutic Antibodies Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Biosimilar Therapeutic Antibodies Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Biosimilar Therapeutic Antibodies Market Size and Growth Rate from 2018-2029
Chapter 2 China Biosimilar Therapeutic Antibodies Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Biosimilar Therapeutic Antibodies Market Status and Competition at home and abroad in 2023
-
2.2.2 China Biosimilar Therapeutic Antibodies Market Status and Competition Analysis in 2023
-
2.2.3 China Biosimilar Therapeutic Antibodies Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Biosimilar Therapeutic Antibodies Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Biosimilar Therapeutic Antibodies Industry Development
Chapter 3 Biosimilar Therapeutic AntibodiesIndustry Chain Analysis
-
3.1 Biosimilar Therapeutic Antibodies Industry Chain
-
3.2 Biosimilar Therapeutic Antibodies Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Biosimilar Therapeutic Antibodies Market
-
3.3 Biosimilar Therapeutic Antibodies Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Biosimilar Therapeutic Antibodies Market
Chapter 4 China Biosimilar Therapeutic Antibodies Market, by Type
-
4.1 China Biosimilar Therapeutic Antibodies Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Biosimilar Therapeutic Antibodies Total Production Volume and Growth Rate from Production Side
-
4.5 China Biosimilar Therapeutic Antibodies Production Volume and Growth Rate, by Type
-
4.5.1 China Biosimilar Therapeutic Antibodies Production Volume and Growth Rate of Type 1
-
4.5.2 China Biosimilar Therapeutic Antibodies Production Volume and Growth Rate of Type 2
-
4.5.3 China Biosimilar Therapeutic Antibodies Production Volume and Growth Rate of Type 3
Chapter 5 China Biosimilar Therapeutic Antibodies Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Biosimilar Therapeutic Antibodies Total Market Size and Growth Rate from Consumption End
-
5.5 China Biosimilar Therapeutic Antibodies Market Size and Growth Rate, by Application
-
5.5.1 China Biosimilar Therapeutic Antibodies Market Size and Growth Rate of Application 1
-
5.5.2 China Biosimilar Therapeutic Antibodies Market Size and Growth Rate of Application 2
-
5.5.3 China Biosimilar Therapeutic Antibodies Market Size and Growth Rate of Application 3
Chapter 6 China Biosimilar Therapeutic Antibodies Market, by Region
-
6.1 China Biosimilar Therapeutic Antibodies Production Volume and Production Value, by Region
-
6.2 China Biosimilar Therapeutic Antibodies Sales Volume and Sales Value, by Region
Chapter 7 North China Biosimilar Therapeutic Antibodies Market Analysis
-
7.1 North China Biosimilar Therapeutic Antibodies Market, by Type
-
7.2 North China Biosimilar Therapeutic Antibodies Market, by Application
Chapter 8 Central China Biosimilar Therapeutic Antibodies Market Analysis
-
8.1 Central China Biosimilar Therapeutic Antibodies Market, by Type
-
8.2 Central China Biosimilar Therapeutic Antibodies Market, by Application
Chapter 9 South China Biosimilar Therapeutic Antibodies Market Analysis
-
9.1 South China Biosimilar Therapeutic Antibodies Market, by Type
-
9.2 South China Biosimilar Therapeutic Antibodies Market, by Application
Chapter 10 East China Biosimilar Therapeutic Antibodies Market Analysis
-
10.1 East China Biosimilar Therapeutic Antibodies Market, by Type
-
10.2 East China Biosimilar Therapeutic Antibodies Market, by Application
Chapter 11 Northeast China Biosimilar Therapeutic Antibodies Market Analysis
-
11.1 Northeast China Biosimilar Therapeutic Antibodies Market, by Type
-
11.2 Northeast China Biosimilar Therapeutic Antibodies Market, by Application
Chapter 12 Southwest China Biosimilar Therapeutic Antibodies Market Analysis
-
12.1 Southwest China Biosimilar Therapeutic Antibodies Market, by Type
-
12.2 Southwest China Biosimilar Therapeutic Antibodies Market, by Application
Chapter 13 Northwest China Biosimilar Therapeutic Antibodies Market Analysis
-
13.1 Northwest China Biosimilar Therapeutic Antibodies Market, by Type
-
13.2 Northwest China Biosimilar Therapeutic Antibodies Market, by Application
Chapter 14 Company Profiles
-
14.1 Affitech
-
14.1.1 Affitech Company Profile
-
14.1.2 Affitech Biosimilar Therapeutic Antibodies Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Binex
-
14.2.1 Binex Company Profile
-
14.2.2 Binex Biosimilar Therapeutic Antibodies Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Affibody
-
14.3.1 Affibody Company Profile
-
14.3.2 Affibody Biosimilar Therapeutic Antibodies Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 3SBio (Shenyang Sunshine Pharmaceutical Co)
-
14.4.1 3SBio (Shenyang Sunshine Pharmaceutical Co) Company Profile
-
14.4.2 3SBio (Shenyang Sunshine Pharmaceutical Co) Biosimilar Therapeutic Antibodies Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 AbbVie
-
14.5.1 AbbVie Company Profile
-
14.5.2 AbbVie Biosimilar Therapeutic Antibodies Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Daiichi Sankyo
-
14.6.1 Daiichi Sankyo Company Profile
-
14.6.2 Daiichi Sankyo Biosimilar Therapeutic Antibodies Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 BioCND
-
14.7.1 BioCND Company Profile
-
14.7.2 BioCND Biosimilar Therapeutic Antibodies Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Daewoong Pharmaceutical Co
-
14.8.1 Daewoong Pharmaceutical Co Company Profile
-
14.8.2 Daewoong Pharmaceutical Co Biosimilar Therapeutic Antibodies Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Affilogic
-
14.9.1 Affilogic Company Profile
-
14.9.2 Affilogic Biosimilar Therapeutic Antibodies Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 CytomX Therapeutics
-
14.10.1 CytomX Therapeutics Company Profile
-
14.10.2 CytomX Therapeutics Biosimilar Therapeutic Antibodies Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 BiOasis Technologies
-
14.11.1 BiOasis Technologies Company Profile
-
14.11.2 BiOasis Technologies Biosimilar Therapeutic Antibodies Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Affimed Therapeutics
-
14.12.1 Affimed Therapeutics Company Profile
-
14.12.2 Affimed Therapeutics Biosimilar Therapeutic Antibodies Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 Biocad
-
14.13.1 Biocad Company Profile
-
14.13.2 Biocad Biosimilar Therapeutic Antibodies Market Performance
-
14.13.3 Product&Service Introduction
-
14.14 Baliopharm
-
14.14.1 Baliopharm Company Profile
-
14.14.2 Baliopharm Biosimilar Therapeutic Antibodies Market Performance
-
14.14.3 Product&Service Introduction
-
14.15 Ablynx
-
14.15.1 Ablynx Company Profile
-
14.15.2 Ablynx Biosimilar Therapeutic Antibodies Market Performance
-
14.15.3 Product&Service Introduction
-
14.16 Allergan
-
14.16.1 Allergan Company Profile
-
14.16.2 Allergan Biosimilar Therapeutic Antibodies Market Performance
-
14.16.3 Product&Service Introduction
-
14.17 Bio Farma
-
14.17.1 Bio Farma Company Profile
-
14.17.2 Bio Farma Biosimilar Therapeutic Antibodies Market Performance
-
14.17.3 Product&Service Introduction
-
14.18 Bayer
-
14.18.1 Bayer Company Profile
-
14.18.2 Bayer Biosimilar Therapeutic Antibodies Market Performance
-
14.18.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Biosimilar Therapeutic Antibodies Industry Research Conclusions
-
15.2 Biosimilar Therapeutic Antibodies Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Biosimilar Therapeutic Antibodies Industry Market Size (2018-2029)
-
Figure China Biosimilar Therapeutic Antibodies Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)
-
Figure China Biosimilar Therapeutic Antibodies Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)
-
Figure China Biosimilar Therapeutic Antibodies Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)
-
Figure China Biosimilar Therapeutic Antibodies Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)
-
Figure China Biosimilar Therapeutic Antibodies Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)
-
Figure China Biosimilar Therapeutic Antibodies Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)
-
Figure North China Biosimilar Therapeutic Antibodies Market Size and Growth Rate from 2018-2029
-
Figure Central China Biosimilar Therapeutic Antibodies Market Size and Growth Rate from 2018-2029
-
Figure South China Biosimilar Therapeutic Antibodies Market Size and Growth Rate from 2018-2029
-
Figure East China Biosimilar Therapeutic Antibodies Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Biosimilar Therapeutic Antibodies Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Biosimilar Therapeutic Antibodies Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Biosimilar Therapeutic Antibodies Market Size and Growth Rate from 2018-2029
-
Figure Biosimilar Therapeutic Antibodies Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Biosimilar Therapeutic Antibodies Market Share by Type in 2018
-
Figure China Biosimilar Therapeutic Antibodies Market Share by Type in 2023
-
Figure China Biosimilar Therapeutic Antibodies Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Biosimilar Therapeutic Antibodies Production Volume and Growth Rate of Type 1 (2018-2023)
-
Figure China Biosimilar Therapeutic Antibodies Production Volume and Growth Rate of Type 2 (2018-2023)
-
Figure China Biosimilar Therapeutic Antibodies Production Volume and Growth Rate of Type 3 (2018-2023)
-
Figure China Biosimilar Therapeutic Antibodies Market Share by Application in 2018
-
Figure China Biosimilar Therapeutic Antibodies Market Share by Application in 2023
-
Figure China Biosimilar Therapeutic Antibodies Total Market Size and Growth Rate from Consumption End
-
Figure China Biosimilar Therapeutic Antibodies Market Size and Growth Rate of Application 1 (2018-2023)
-
Figure China Biosimilar Therapeutic Antibodies Market Size and Growth Rate of Application 2 (2018-2023)
-
Figure China Biosimilar Therapeutic Antibodies Market Size and Growth Rate of Application 3 (2018-2023)
-
Table China Biosimilar Therapeutic Antibodies Production Volume by Region (2018-2023)
-
Table China Biosimilar Therapeutic Antibodies Production Volume Share by Region (2018-2023)
-
Figure China Biosimilar Therapeutic Antibodies Production Volume Share by Region (2018-2023)
-
Table China Biosimilar Therapeutic Antibodies Production Value by Region (2018-2023)
-
Table China Biosimilar Therapeutic Antibodies Production Value Share by Region (2018-2023)
-
Figure China Biosimilar Therapeutic Antibodies Production Value Share by Region (2018-2023)
-
Table China Biosimilar Therapeutic Antibodies Sales Volume by Region (2018-2023)
-
Table China Biosimilar Therapeutic Antibodies Sales Volume Share by Region (2018-2023)
-
Figure China Biosimilar Therapeutic Antibodies Sales Volume Share by Region (2018-2023)
-
Table China Biosimilar Therapeutic Antibodies Sales Value by Region (2018-2023)
-
Table China Biosimilar Therapeutic Antibodies Sales Value Share by Region (2018-2023)
-
Figure China Biosimilar Therapeutic Antibodies Sales Value Share by Region (2018-2023)
-
Table North China Biosimilar Therapeutic Antibodies Production Volume by Type (2018-2023)
-
Table North China Biosimilar Therapeutic Antibodies Production Volume Share by Type (2018-2023)
-
Figure North China Biosimilar Therapeutic Antibodies Production Volume Share by Type (2018-2023)
-
Table North China Biosimilar Therapeutic Antibodies Sales Volume by Application (2018-2023)
-
Table North China Biosimilar Therapeutic Antibodies Sales Volume Share by Application (2018-2023)
-
Figure North China Biosimilar Therapeutic Antibodies Sales Volume Share by Application (2018-2023)
-
Table Central China Biosimilar Therapeutic Antibodies Production Volume by Type (2018-2023)
-
Table Central China Biosimilar Therapeutic Antibodies Production Volume Share by Type (2018-2023)
-
Figure Central China Biosimilar Therapeutic Antibodies Production Volume Share by Type (2018-2023)
-
Table Central China Biosimilar Therapeutic Antibodies Sales Volume by Application (2018-2023)
-
Table Central China Biosimilar Therapeutic Antibodies Sales Volume Share by Application (2018-2023)
-
Figure Central China Biosimilar Therapeutic Antibodies Sales Volume Share by Application (2018-2023)
-
Table South China Biosimilar Therapeutic Antibodies Production Volume by Type (2018-2023)
-
Table South China Biosimilar Therapeutic Antibodies Production Volume Share by Type (2018-2023)
-
Figure South China Biosimilar Therapeutic Antibodies Production Volume Share by Type (2018-2023)
-
Table South China Biosimilar Therapeutic Antibodies Sales Volume by Application (2018-2023)
-
Table South China Biosimilar Therapeutic Antibodies Sales Volume Share by Application (2018-2023)
-
Figure South China Biosimilar Therapeutic Antibodies Sales Volume Share by Application (2018-2023)
-
Table East China Biosimilar Therapeutic Antibodies Production Volume by Type (2018-2023)
-
Table East China Biosimilar Therapeutic Antibodies Production Volume Share by Type (2018-2023)
-
Figure East China Biosimilar Therapeutic Antibodies Production Volume Share by Type (2018-2023)
-
Table East China Biosimilar Therapeutic Antibodies Sales Volume by Application (2018-2023)
-
Table East China Biosimilar Therapeutic Antibodies Sales Volume Share by Application (2018-2023)
-
Figure East China Biosimilar Therapeutic Antibodies Sales Volume Share by Application (2018-2023)
-
Table Northeast China Biosimilar Therapeutic Antibodies Production Volume by Type (2018-2023)
-
Table Northeast China Biosimilar Therapeutic Antibodies Production Volume Share by Type (2018-2023)
-
Figure Northeast China Biosimilar Therapeutic Antibodies Production Volume Share by Type (2018-2023)
-
Table Northeast China Biosimilar Therapeutic Antibodies Sales Volume by Application (2018-2023)
-
Table Northeast China Biosimilar Therapeutic Antibodies Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Biosimilar Therapeutic Antibodies Sales Volume Share by Application (2018-2023)
-
Table Southwest China Biosimilar Therapeutic Antibodies Production Volume by Type (2018-2023)
-
Table Southwest China Biosimilar Therapeutic Antibodies Production Volume Share by Type (2018-2023)
-
Figure Southwest China Biosimilar Therapeutic Antibodies Production Volume Share by Type (2018-2023)
-
Table Southwest China Biosimilar Therapeutic Antibodies Sales Volume by Application (2018-2023)
-
Table Southwest China Biosimilar Therapeutic Antibodies Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Biosimilar Therapeutic Antibodies Sales Volume Share by Application (2018-2023)
-
Table Northwest China Biosimilar Therapeutic Antibodies Production Volume by Type (2018-2023)
-
Table Northwest China Biosimilar Therapeutic Antibodies Production Volume Share by Type (2018-2023)
-
Figure Northwest China Biosimilar Therapeutic Antibodies Production Volume Share by Type (2018-2023)
-
Table Northwest China Biosimilar Therapeutic Antibodies Sales Volume by Application (2018-2023)
-
Table Northwest China Biosimilar Therapeutic Antibodies Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Biosimilar Therapeutic Antibodies Sales Volume Share by Application (2018-2023)
-
Table Affitech Company Profile
-
Table Affitech Biosimilar Therapeutic Antibodies Revenue, Price and Gross (2018-2023)
-
Table Binex Company Profile
-
Table Binex Biosimilar Therapeutic Antibodies Revenue, Price and Gross (2018-2023)
-
Table Affibody Company Profile
-
Table Affibody Biosimilar Therapeutic Antibodies Revenue, Price and Gross (2018-2023)
-
Table 3SBio (Shenyang Sunshine Pharmaceutical Co) Company Profile
-
Table 3SBio (Shenyang Sunshine Pharmaceutical Co) Biosimilar Therapeutic Antibodies Revenue, Price and Gross (2018-2023)
-
Table AbbVie Company Profile
-
Table AbbVie Biosimilar Therapeutic Antibodies Revenue, Price and Gross (2018-2023)
-
Table Daiichi Sankyo Company Profile
-
Table Daiichi Sankyo Biosimilar Therapeutic Antibodies Revenue, Price and Gross (2018-2023)
-
Table BioCND Company Profile
-
Table BioCND Biosimilar Therapeutic Antibodies Revenue, Price and Gross (2018-2023)
-
Table Daewoong Pharmaceutical Co Company Profile
-
Table Daewoong Pharmaceutical Co Biosimilar Therapeutic Antibodies Revenue, Price and Gross (2018-2023)
-
Table Affilogic Company Profile
-
Table Affilogic Biosimilar Therapeutic Antibodies Revenue, Price and Gross (2018-2023)
-
Table CytomX Therapeutics Company Profile
-
Table CytomX Therapeutics Biosimilar Therapeutic Antibodies Revenue, Price and Gross (2018-2023)
-
Table BiOasis Technologies Company Profile
-
Table BiOasis Technologies Biosimilar Therapeutic Antibodies Revenue, Price and Gross (2018-2023)
-
Table Affimed Therapeutics Company Profile
-
Table Affimed Therapeutics Biosimilar Therapeutic Antibodies Revenue, Price and Gross (2018-2023)
-
Table Biocad Company Profile
-
Table Biocad Biosimilar Therapeutic Antibodies Revenue, Price and Gross (2018-2023)
-
Table Baliopharm Company Profile
-
Table Baliopharm Biosimilar Therapeutic Antibodies Revenue, Price and Gross (2018-2023)
-
Table Ablynx Company Profile
-
Table Ablynx Biosimilar Therapeutic Antibodies Revenue, Price and Gross (2018-2023)
-
Table Allergan Company Profile
-
Table Allergan Biosimilar Therapeutic Antibodies Revenue, Price and Gross (2018-2023)
-
Table Bio Farma Company Profile
-
Table Bio Farma Biosimilar Therapeutic Antibodies Revenue, Price and Gross (2018-2023)
-
Table Bayer Company Profile
-
Table Bayer Biosimilar Therapeutic Antibodies Revenue, Price and Gross (2018-2023)
-
